NRG Oncology/RTOG 9601, a phase III trial in prostate cancer patients: Anti-androgen therapy (AAT) with bicalutamide during and after salvage radiation therapy (RT) following radical prostatectomy (RP) and an elevated PSA. Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Shipley, William U
  • Pugh, Stephanie L
  • Lukka, Himu
  • Major, Pierre
  • Heney, Niall M
  • Grignon, David A
  • Sartor, Oliver
  • Patel, Malti
  • Bahary, Jean-Paul
  • Zietman, Anthony L
  • Pisansky, Thomas Michael
  • Zeitzer, Kenneth Lee
  • Lawton, Colleen Anne
  • Feng, Felix Yi-Chung
  • Lovett, Richard Dana
  • Balogh, Alexander G
  • Souhami, Luis
  • Rosenthal, Seth A
  • Kerlin, Kevin
  • Sandler, Howard M

publication date

  • January 10, 2016